AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home iLABMED Article
PDF (1.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Precision Diagnosis of Helicobacter pylori Infection and Its Drug Resistance

Bin Tang1 , Pu Li1, Xuhu Mao2( )
Department of Clinical Laboratory, Chongqing University Jiangjin Hospital, School of Medicine, Chongqing University, Chongqing, China
Department of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing, China

Bin Tang and Pu Li contributed equally to this work and shared the co‐first authorship.

Show Author Information

Abstract

Helicobacter pylori, a gram‐negative microaerophilic bacterium, is implicated in a broad spectrum of upper gastrointestinal disorders, including chronic gastritis, peptic ulcers, gastric cancer, and even certain extragastric diseases. Its ability to colonize and persist within the host is driven by a complex arsenal of colonization and virulence factors, underscoring the intricate dynamics of host–pathogen interactions. The clinical management of H. pylori remains challenging, primarily due to the absence of commercially available vaccines and the increasing prevalence of multidrug resistance. Accurate and reliable detection methods are therefore critical for preventing infections, identifying antibiotic resistance, and assessing treatment efficacy. Currently, both invasive and non‐invasive diagnostic approaches are employed, each with unique strengths and limitations. This review provides a comprehensive overview of H. pylori pathogenesis, diagnostic strategies, and therapeutic interventions, highlighting the latest advancements in diagnostic and treatment technologies. By critically evaluating existing methods and exploring innovative approaches, this review aims to support future progress in the effective management of this globally prevalent pathogen.

Graphical Abstract

This review comprehensively examines Helicobacter pylori's pathogenesis, clinical impact, and challenges in diagnosis and treatment, emphasizing its role in gastric diseases and rising multidrug resistance. It highlights advancements in diagnostic techniques, including precision methods and antimicrobial susceptibility testing (AST), while addressing barriers to their implementation. By evaluating current strategies and exploring innovative approaches, the review aims to guide future efforts in improving the management and eradication of this globally significant pathogen.

References

【1】
【1】
 
 
iLABMED
Pages 106-123

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Tang B, Li P, Mao X. Precision Diagnosis of Helicobacter pylori Infection and Its Drug Resistance. iLABMED, 2025, 3(1): 106-123. https://doi.org/10.1002/ila2.73

1673

Views

111

Downloads

2

Crossref

0

CSCD

Received: 19 September 2024
Revised: 02 December 2024
Accepted: 03 December 2024
Published: 21 February 2025
© 2025 The Author(s). Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.